Autologous bone marrow-derived mononuclear cell transplants can reduce diabetic amputations
Autologous (self-donated) mononuclear cells derived from bone marrow (BMMNCs) have been found to significantly induce vascular growth when transplanted into patients with diabetes who are suffering from critical limb ischemia ...